<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
ACRS
Aclaris Therapeutics
$
()


  • Aclaris Therapeutics expects cash to fund operations into 2028

    8/7/2024 - 07:03am
  • Aclaris Therapeutics reports Q2 EPS (15c), consensus (20c)

    8/7/2024 - 07:02am
  • Aclaris sells portion of OLUMIANT royalties to Omers for $26.5M upfront

    7/16/2024 - 16:12pm
  • Aclaris Therapeutics reports Q1 EPS (24c), consensus (29c)

    5/7/2024 - 16:07pm
  • Aclaris Therapeutics reports Q4 EPS (2c), consensus (34c)

    2/27/2024 - 07:07am
  • Aclaris Therapeutics just downgraded at H.C. Wainwright, here's why

    1/22/2024 - 06:07am
  • Aclaris Therapeutics conducting strategic review of business

    1/16/2024 - 07:14am
  • Aclaris Therapeutics CEO Douglas Manion to step down

    1/16/2024 - 07:13am
  • Aclaris Therapeutics just downgraded at BTIG, here's why

    1/11/2024 - 06:17am
  • Aclaris downgraded to Hold at Jefferies after ATI-1777 data reported

    1/10/2024 - 11:26am
  • Jefferies gets more bearish on Aclaris Therapeutics, downgrades shares

    1/10/2024 - 11:21am
  • Aclaris announces Phase 2b study of ATI-1777 met primary efficacy endpoint

    1/10/2024 - 07:07am
  • Aclaris Therapeutics to reduce workforce by 46%, provides corporate updates

    12/19/2023 - 16:06pm
  • Aclaris in alopecia patent license pact with Sun Pharma includes $15M upfront

    12/5/2023 - 16:09pm
  • Largest borrow rate increases among liquid names

    11/29/2023 - 08:45am
dynamic_feed Breaking News